Speedinvest is a leading European early-stage venture capital firm with more than €1 billion AuM. Based in Vienna, Berlin, London, Munich, and Paris, their dedicated sector teams invest in pre-seed and seed-stage technology startups across Deep Tech, Fintech, Health, Industrial Tech, Marketplaces & Consumer, and SaaS.
Portfolio 18 Investments
ARX Robotics
defense, robotics, autonomy
series-a
€11 M
Jul 2025
Lead
Due
Fintech, Payments, Blockchain
seed
€7.3 M
Jul 2025
Lead
enliteAI
artificial intelligence, energy
series-a
€2 M
Aug 2025
Investor
Qovery
DevOps, Cloud infrastructure, AI
series-a
€13 M
Sep 2025
Investor
refurbed
marketplace, electronics, e-commerce, circular economy, refurbishment
unspecified
€50 M
Oct 2025
Investor
Mimic Robotics
robotics, artificial intelligence, hardware
seed
€16 M
Nov 2025
Lead
GetVocal
customer support, conversational AI, enterprise software
series-a
€26 M
Nov 2025
Investor
Runware
artificial intelligence, infrastructure, media-tech, machine learning
series-a
€50 M
Dec 2025
Investor
Polaron
materials, manufacturing, artificial intelligence, automotive, energy
unspecified
€8 M
Feb 2026
Investor
Flinn
medtech, healthcare
unspecified
$20 M
Feb 2026
Investor
Diligent AI
financial crime compliance, regtech, artificial intelligence, fintech
seed
$2.5 M
Mar 2026
Lead
Emmi AI
artificial intelligence, industrial AI, physics AI
unspecified
undisclosed amount
Mar 2026
Investor
Rivia
healthtech, clinical trials, data infrastructure, artificial intelligence, biotech software
series-a
$15 M
Mar 2026
Investor
Eunice
fintech, artificial intelligence, regtech, compliance, private markets
seed
$8 M
Mar 2026
Lead
Blocks
cloud cost management, artificial intelligence, fintech
pre-seed
$6 M
Apr 2026
Lead
Fifth Dimension
artificial intelligence, real estate, enterprise software, fintech
series-a
$26 M
May 2026
Investor
Kyrok
artificial intelligence, supply chain management, pharmaceuticals, chemicals, enterprise software
pre-seed
€3.1 M
Jun 2026
Lead
Astral Systems
Measuring and Control Instrument Manufacturing, Nuclear Fusion, Medical Isotope Production
series-a
£23 M
Jun 2026
Investor